Margaret J Gentles, Age 9668 Day St, Bloomfield, NJ 07003

Margaret Gentles Phones & Addresses

68 Day St, Bloomfield, NJ 07003 (973) 338-4192

Newton, NJ

Green Village, NJ

68 Day St, Bloomfield, NJ 07003

Social networks

Margaret J Gentles

Linkedin

Mentions for Margaret J Gentles

Margaret Gentles resumes & CV records

Resumes

Margaret Gentles Photo 12

Margaret Gentles

Publications & IP owners

Us Patents

Ester And Alkoxy Substituted Benzopyrans

US Patent:
5412104, May 2, 1995
Filed:
Mar 1, 1993
Appl. No.:
8/030186
Inventors:
Adriano Afonso - West Caldwell NJ
Jay Weinstein - Upper Montclair NJ
Margaret J. Gentles - Bloomfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3147
US Classification:
548525
Abstract:
Compounds useful as antihypertensive agents and useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by Formula 1. 0: ##STR1## and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1. 0 are disclosed. Methods of treating a viral infection using compounds represented by Formula 1. 0 are disclosed. Also disclosed are methods of treating hypertension using compounds of Formula 1. 0 wherein R is selected from the group consisting of H, halogen and --C(O)OR. sup. 6 ; and R. sup. 1 is selected from the group consisting of --OR. sup. 14, --O(CH. sub. 2). sub. a C(H). sub. 3-i Z. sub. i and --O(CH. sub. 2). sub. h N(R. sup. 15). sub. 2.

Alkyl And Acyl Substituted Quinolines

US Patent:
5382572, Jan 17, 1995
Filed:
Mar 1, 1993
Appl. No.:
8/030187
Inventors:
Adriano Afonso - West Caldwell NJ
Jay Weinstein - Upper Montclair NJ
Margaret J. Gentles - Bloomfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D21522
A61K 3137
US Classification:
514 82
Abstract:
Compounds useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by Formula 1. 0: ##STR1## and their pharmaceutically acceptable salts and solvates; wherein: (A) X is selected from the group consisting of N--R. sup. 3, O, S, and C(R. sup. 3). sub. 2 ; (B) R. sup. 3 is selected from H and a range of substituents; (C) R. sup. 1 is an etherifying or esterifying group; (D) R. sup. 2 is selected from a range of substituents; (E) m is 0 or an integer from 1 to 4; and (F) R. sup. 4 and R. sup. 5 are the same and are selected from alkyl and acyl groups; together with the pharmaceutically acceptable salts of the compounds of Formula 1. 0 that are acidic or basic. Pharmaceutical compositions containing compounds represented by Formula 1.

Certain N-Substituted 3-Oximino-2,4-Dioxoquinolin-2,4-(1H)Diones Useful For Treating Viral Infections

US Patent:
5190956, Mar 2, 1993
Filed:
Sep 7, 1990
Appl. No.:
7/579919
Inventors:
Adriano Afonso - West Caldwell NJ
Jay Weinstein - Upper Montclair NJ
Margaret J. Gentles - Bloomfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D21520
C07D21522
A61K 3147
US Classification:
514312
Abstract:
Compounds useful as antiviral agents against DNA containing viruses, such as herpes group viruses, are disclosed. The compounds are selected from the group consisting of: ##STR1## and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1. 00 are disclosed. Also disclosed are methods of treating a viral infection using compounds represented by Formula 1. 00 The compounds of Formula 1. 00 are also useful as intermediates to compounds of: ##STR2## Compounds of Formula 1. 0 are useful as antiviral agents against the same viruses that the compounds of Formula 1. 00 are useful against.

Acyl And Alkoxy Substituted Quinolines

US Patent:
5378694, Jan 3, 1995
Filed:
Mar 1, 1993
Appl. No.:
7/983519
Inventors:
Adriano Afonso - West Caldwell NJ
Jay Weinstein - Upper Montclair NJ
Margaret J. Gentles - Bloomfield NJ
Stuart B. Rosenblum - West Orange NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D21556
A61K 3147
US Classification:
514 82
Abstract:
Compounds useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are are represented by compounds of Formula 1. 0: ##STR1## and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1. 0 and methods of treating a viral infection using compounds represented by Formula 1. 0 are disclosed. Also disclosed are compounds useful as antihypertensive agents and methods of treating hypertension using such compounds. The antihypertensive agents are compounds represented by Formula 1. 0 wherein R. sup. 4 is selected from the group consisting of alkyl and aminoalkyl. Preferably R. sup. 1 is H.

Antiviral Compounds And Antihypertensive Compounds

US Patent:
5942522, Aug 24, 1999
Filed:
Feb 26, 1997
Appl. No.:
8/806585
Inventors:
Adriano Afonso - West Caldwell NJ
Jay Weinstein - Upper Montclair NJ
Margaret Jevnik Gentles - Bloomfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 3137
C07D21522
US Classification:
514312
Abstract:
Compounds useful as antihypertensive agents and useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by Formula 1. 0: ##STR1## and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1. 0 are disclosed. Methods of treating a viral infection using compounds represented by Formula 1. 0 are disclosed. Also disclosed are methods of treating hypertension using compounds of Formula 1. 0 wherein R is selected from the group consisting of H, halogen and --C(O)OR. sup. 6 ; and R. sup. 1 is selected from the group consisting of --OR. sup. 14, --O(CH. sub. 2). sub. a C(H). sub. 3-i Z. sub. i and --O(CH. sub. 2). sub. h N(R. sup. 15). sub. 2.

Antiviral Compounds And Antihypertensive Compounds

US Patent:
5175151, Dec 29, 1992
Filed:
Feb 5, 1992
Appl. No.:
7/830958
Inventors:
Adriano Afonso - West Caldwell NJ
Jay Weinstein - Upper Montclair NJ
Margaret J. Gentles - Bloomfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D21556
US Classification:
514 63
Abstract:
Compounds useful as antihypertensive agents, or antiviral agents against DNA containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by Formula 1. 0: ##STR1## and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1. 0 are disclosed. Also disclosed are methods of treating hypertension or a viral infection using compounds represented by Formulas 1. Also disclosed is a compound of Structure B ##STR2## useful as an intermediate in producing compounds of Formula 1. A process for preparing the compounds of Formula 1. 0 is also disclosed. In the process a compound of Structure B ##STR3## is reacted with an alkoxide R. sub. 1 O. sup. - M. sup. + in a solvent comprising the corresponding alcohol R. sub. 1 OH of the alkoxide.

Process For The Preparation Of 7.Alpha.-Halogeno-3-Oxo-4-Dehydro Steroids And Novel 7.Alpha.-Halogeno Derivatives Produced Thereby

US Patent:
4076708, Feb 28, 1978
Filed:
Dec 22, 1976
Appl. No.:
5/753257
Inventors:
Michael J. Green - Kendall Park NJ
Elliot L. Shapiro - Cedar Grove NJ
Margaret A. Gentles - Bloomfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07J 7100
US Classification:
26023957
Abstract:
3-Oxo-6-unsubstituted-7. alpha. -halogeno-4-dehydro steroids, wherein said halogen is chlorine, bromine or iodine, are prepared by reaction of a 3-oxo-6,7-di-unsubstituted-4,6-bis-dehydro steroid with at least an equimolar quantity of the corresponding hydrogen halide in a non-reactive organic solvent at temperatures no higher than about 30. degree. C, and then are isolated by removal of said solvent and any excess acid at temperatures no higher than about 25. degree. C without subjecting said 3-oxo-6-unsubstituted-7. alpha. -halogeno-4-dehydro steroid to a basic medium. A preferred species of this process is that wherein the starting steroid is a 3,20-dioxo-9-unsubstituted-11-oxygenated-1,4,6-pregnatriene-17,21-diol or ester thereof, preferably a 17,21-di-lower alkanoate or a 17-benzoate 21-lower alkanoate ester thereof, whereby is prepared in good yields a 3,20-dioxo-7. alpha. -halogeno-1,4-pregnadiene-17. alpha. ,21-diol or ester thereof, useful as topical anti-inflammatory agents.

Antiviral Quinolinone Compounds

US Patent:
5179107, Jan 12, 1993
Filed:
Dec 19, 1991
Appl. No.:
7/811890
Inventors:
Adriano Afonso - West Caldwell NJ
Jay Weinstein - Upper Montclair NJ
Margaret J. Gentles - Bloomfield NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D21522
A61K 3147
A01N 4342
US Classification:
514312
Abstract:
Compounds useful as antiviral agents against DNA containing viruses, such as herpes group viruses, are disclosed. The compounds are selected from the group consisting of: ##STR1## and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1. 0 are disclosed. Also disclosed are methods of treating a viral infection using compounds represented by Formula 1. A process for making compounds of Formula 1. 0 from the appropriate 3-oximino-quinolin-2,4(1H)-dione (Formula 2. 5) is also disclosed. The process comprises reductively hydrolyzing an appropriate 3-oximino-quinolin-2,4(1H)-dione (Formula 2. 5) in a mixture with a hydrogenation catalyst and an acidic solvent mixture.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.